How long is the flu contagious, and how long should I stay home?

After being practically non-existent last year, the flu is slowly coming back across the country. The University of Michigan is currently grappling with a flu outbreak and cases of the virus have starting creeping up nationwide.

Rochelle Walensky, M.D., M.P.H., director of the Centers for Disease Control and Prevention (CDC) warned during a press briefing last month that this year’s flu season could be a doozy.

“Last year there were very few flu cases, largely because of masking and physical distancing and other prevention measures put in place for the COVID-19 pandemic,” she said.

Between October 3, 2020 and July 24, 2021, the CDC saw just 2,136 positive flu tests out of 1.3 million specimens tested by clinical labs, according to data published in JAMA. There were 736 deaths last season from the flu and, by comparison, the 2019–2020 flu season saw an estimated 35 million flu-related illnesses and 20,000 flu-related deaths, per the CDC.

Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost effectively than the traditional biotech model. 

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Poolbeg Pharma

More articles like this

Poolbeg Pharma updates on Immunomodulator II Patent

Poolbeg Pharma has announced that it has received a Notice of Allowance from the US Patent Office in relation to its Immunomodulator II patent application. A Notice of Allowance is a precursor to the expected formal grant

February hires in Pharma

February may be the shortest month, but we got an extra day this year and that left plenty of time for personnel announcements in the pharma world. Read on for a roundup of the month’s hiring

Poolbeg Pharma’s Cathal Friel assumes role of Executive Chairman

Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, has announced a change of Board role and the Remuneration Committee’s approval of

What will cancer therapy look like in 2034?

Drugs like PARP inhibitors and chimeric antigen receptor (CAR) therapies, and advancements in artificial intelligence in drug discovery, have spurred hope for improved cancer care in the past year. Rigorous research has paved the way for a